247 related articles for article (PubMed ID: 14570767)
41. Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation.
Ohyama K; Murayama N; Shimizu M; Yamazaki H
Xenobiotica; 2014 Jan; 44(1):10-6. PubMed ID: 23777257
[TBL] [Abstract][Full Text] [Related]
42. In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.
Emoto C; Murase S; Sawada Y; Iwasaki K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):351-7. PubMed ID: 16272753
[TBL] [Abstract][Full Text] [Related]
43. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.
Chatterjee P; Franklin MR
Drug Metab Dispos; 2003 Nov; 31(11):1391-7. PubMed ID: 14570772
[TBL] [Abstract][Full Text] [Related]
44. Effects of eupatilin and jaceosidin on cytochrome p450 enzyme activities in human liver microsomes.
Ji HY; Kim SY; Kim DK; Jeong JH; Lee HS
Molecules; 2010 Sep; 15(9):6466-75. PubMed ID: 20877236
[TBL] [Abstract][Full Text] [Related]
45. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
[TBL] [Abstract][Full Text] [Related]
46. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study.
Wójcikowski J; Daniel WA
Pharmacol Rep; 2009; 61(5):851-8. PubMed ID: 19904008
[TBL] [Abstract][Full Text] [Related]
47. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
48. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
49. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug.
Niwa T; Inoue S; Shiraga T; Takagi A
Biol Pharm Bull; 2005 Jan; 28(1):188-91. PubMed ID: 15635191
[TBL] [Abstract][Full Text] [Related]
50. The potential of Hypoxis hemerocallidea for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; Bouic PJ; Rosenkranz B
Pharm Biol; 2013 Dec; 51(12):1499-507. PubMed ID: 23844611
[TBL] [Abstract][Full Text] [Related]
51. In vitro inhibition of human cytochrome P450 by cudratricusxanthone A.
Sim J; Choi E; Lee YM; Jeong GS; Lee S
Food Chem Toxicol; 2015 Jul; 81():171-175. PubMed ID: 25936586
[TBL] [Abstract][Full Text] [Related]
52. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
[TBL] [Abstract][Full Text] [Related]
53. Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol.
Alvarez-Diez TM; Zheng J
Chem Res Toxicol; 2004 Feb; 17(2):150-7. PubMed ID: 14967002
[TBL] [Abstract][Full Text] [Related]
54. Mechanism-based inactivation of CYP2C11 by diclofenac.
Masubuchi Y; Ose A; Horie T
Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
[TBL] [Abstract][Full Text] [Related]
55. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
[TBL] [Abstract][Full Text] [Related]
56. In vitro assessment of time-dependent inhibitory effects on CYP2C8 and CYP3A activity by fourteen protein kinase inhibitors.
Filppula AM; Neuvonen PJ; Backman JT
Drug Metab Dispos; 2014 Jul; 42(7):1202-9. PubMed ID: 24713129
[TBL] [Abstract][Full Text] [Related]
57. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
58. Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes.
Kim JY; Lee S; Kim DH; Kim BR; Park R; Lee BM
J Toxicol Environ Health A; 2002 Mar; 65(5-6):373-81. PubMed ID: 11936218
[TBL] [Abstract][Full Text] [Related]
59. Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.
Stresser DM; Perloff ES; Mason AK; Blanchard AP; Dehal SS; Creegan TP; Singh R; Gangl ET
Drug Metab Dispos; 2016 Aug; 44(8):1424-30. PubMed ID: 27149898
[TBL] [Abstract][Full Text] [Related]
60. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]